Literature DB >> 2709500

Assessment of screening for prostate cancer using the digital rectal examination.

G W Chodak1, P Keller, H W Schoenberg.   

Abstract

An early detection study for prostate cancer was initiated to determine the effect of routine digital rectal examinations on the stage of prostate cancer at diagnosis. A prostate biopsy was recommended if induration, asymmetry or nodules were detected on the digital examination. During a 6-year period 4,160 examinations were performed on 2,131 men more than 45 years old. A prostate biopsy was performed on 144 men and 36 malignant tumors were detected, of which 68 per cent were clinically localized. Pelvic lymph node metastases were found in 6 per cent of the surgically staged cancer patients and in 10 per cent of the patients who had a high grade tumor. Surgical staging revealed that 50 per cent of the patients with clinical stage B disease were upstaged to stage C or D1 disease. These results suggest that mass screening programs using digital examination may not add sufficient benefit over conventional medical care to warrant the expense. Definitive proof that screening can lower the mortality rate from prostate cancer can be obtained only by a prospective randomized clinical trial.

Entities:  

Mesh:

Year:  1989        PMID: 2709500     DOI: 10.1016/s0022-5347(17)41192-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Is digital screening for prostatic cancer effective?

Authors:  D B Louria
Journal:  Bull N Y Acad Med       Date:  1992-11

2.  Prostate mechanical imaging: a new method for prostate assessment.

Authors:  Robert E Weiss; Vladimir Egorov; Suren Ayrapetyan; Noune Sarvazyan; Armen Sarvazyan
Journal:  Urology       Date:  2008-03       Impact factor: 2.649

Review 3.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

Review 4.  Biomarker research in prostate cancer--towards utility, not futility.

Authors:  Sheng Fei Oon; Stephen R Pennington; John M Fitzpatrick; R William G Watson
Journal:  Nat Rev Urol       Date:  2011-03       Impact factor: 14.432

5.  Does screening for prostate cancer identify clinically important disease?

Authors:  M R Feneley
Journal:  Ann R Coll Surg Engl       Date:  1999-05       Impact factor: 1.891

Review 6.  Comparison of prostate-specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer.

Authors:  Sagnik Sengupta; Mena Asha Krishnan; Sudeshna Chattopadhyay; Venkatesh Chelvam
Journal:  Cancer Rep (Hoboken)       Date:  2019-04-02

Review 7.  Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer.

Authors:  Michael A Jacobs; Ronald Ouwerkerk; Kyle Petrowski; Katarzyna J Macura
Journal:  Top Magn Reson Imaging       Date:  2008-12

8.  Attitudes of African Americans regarding screening for prostate cancer.

Authors:  S B Robinson; M Ashley; M A Haynes
Journal:  J Natl Med Assoc       Date:  1996-04       Impact factor: 1.798

Review 9.  Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies.

Authors:  Jennifer K Logan; Soroush Rais-Bahrami; Baris Turkbey; Andrew Gomella; Hayet Amalou; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  BJU Int       Date:  2014-05-22       Impact factor: 5.588

Review 10.  Screening for prostate cancer.

Authors:  M L Cher; P R Carroll
Journal:  West J Med       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.